Literature DB >> 31770459

The cross-sectional association between diabetes and orthostatic hypotension in community-dwelling older people.

J Gannon1, P Claffey1, E Laird2, L Newman2, R A Kenny1,2, R Briggs1,2.   

Abstract

AIMS: Orthostatic hypotension is a recognized complication of diabetes, but studies examining prevalence in diabetes are limited. The aim of this study was to ascertain the prevalence of orthostatic hypotension and the pattern of orthostatic BP response in a cohort of people with diabetes aged ≥ 50 years, embedded within the Irish Longitudinal Study of Ageing.
METHODS: Orthostatic hypotension was defined as a drop in systolic blood pressure (SBP) ≥ 20 mmHg or drop in diastolic blood pressure (DBP) ≥ 10 mmHg at 30 s after standing. Diabetes was defined by self-report but cross-checked against HbA1c and medication records. Multilevel mixed effects linear regression models were used to compare orthostatic BP in people with and without diabetes.
RESULTS: Some 3222 people were included, 7% (213 of 3222) of whom had diabetes. Prevalence of orthostatic hypotension in the group with diabetes was 22% (46 of 213) vs. 13% in those without diabetes; χ2 = 12.43; P < 0.001. Multilevel models demonstrated prolonged recovery of DBP in people with diabetes, with only 41% (87 of 213) returning to baseline by 60 s. Logistic regression models demonstrated that diabetes was associated with a significantly increased likelihood of orthostatic hypotension (odds ratio 1.84, 95% confidence interval 1.30-2.59; P = 0.001) and this remained robust after controlling for covariates.
CONCLUSION: Over one-fifth of older people with diabetes had orthostatic hypotension. Recovery of DBP is related to dynamic changes in total peripheral resistance and impairment of this baroreflex-mediated response may explain the higher prevalence in diabetes. Given the prognostic implications when co-existing with diabetes, orthostatic hypotension may represent a potentially modifiable risk factor for adverse outcomes in late-life diabetes.
© 2019 Diabetes UK.

Entities:  

Year:  2019        PMID: 31770459     DOI: 10.1111/dme.14187

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  3 in total

1.  Prognostic value of postural hypotension in hospitalized patients with heart failure.

Authors:  Tsutomu Sunayama; Daichi Maeda; Yuya Matsue; Nobuyuki Kagiyama; Kentaro Jujo; Kazuya Saito; Kentaro Kamiya; Hiroshi Saito; Yuki Ogasawara; Emi Maekawa; Masaaki Konishi; Takeshi Kitai; Kentaro Iwata; Hiroshi Wada; Masaru Hiki; Taishi Dotare; Takatoshi Kasai; Hirofumi Nagamatsu; Tetsuya Ozawa; Katsuya Izawa; Shuhei Yamamoto; Naoki Aizawa; Ryusuke Yonezawa; Kazuhiro Oka; Shin-Ichi Momomura; Tohru Minamino
Journal:  Sci Rep       Date:  2022-02-18       Impact factor: 4.379

Review 2.  Management of Type 2 Diabetes Mellitus in Elderly Patients with Frailty and/or Sarcopenia.

Authors:  Jaime Sanz-Cánovas; Almudena López-Sampalo; Lidia Cobos-Palacios; Michele Ricci; Halbert Hernández-Negrín; Juan José Mancebo-Sevilla; Elena Álvarez-Recio; María Dolores López-Carmona; Luis Miguel Pérez-Belmonte; Ricardo Gómez-Huelgas; Maria Rosa Bernal-López
Journal:  Int J Environ Res Public Health       Date:  2022-07-16       Impact factor: 4.614

3.  Metformin may adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes: substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trial.

Authors:  Christian Stevns Hansen; Louise Lundby-Christiansen; Lise Tarnow; Christian Gluud; Christoffer Hedetoft; Birger Thorsteinsson; Bianca Hemmingsen; Niels Wiinberg; Simone B Sneppen; Søren S Lund; Thure Krarup; Sten Madsbad; Thomas Almdal; Bendix Carstensen; Marit E Jørgensen
Journal:  Cardiovasc Diabetol       Date:  2020-09-26       Impact factor: 9.951

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.